Contract Manufacturing
Centivax Partners with Australia’s BioCina for cGMP Manufacturing of Universal Influenza Vaccine
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax...
October 10, 2024 | News
SK bioscience Invests USD 3 Million in FinaBio to Enhance Next-Generation Conjugate Vaccine Development
SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. With the agreement, SK bio...
October 08, 2024 | News
Thermo Fisher Scientific Launches Accelerator™ Drug Development: Transforming Drug Development with Comprehensive CDMO and CRO Services
Company Launches Accelerator™ Drug Development, 360° Contract Development and Manufacturing Organization (CDMO) and Contract Research Organizatio...
October 07, 2024 | News
SK Bioscience Acquires IDT Biologika to Accelerate Global Growth and Dominate the CDMO Industry
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in r...
October 02, 2024 | News
SK Pharmteco Invests $260 Million in New Sejong Facility to Boost Small Molecule and Peptide Production
- Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong - More than 300 new employees to be hired for the anticipated 2026 ...
September 30, 2024 | News
Bloomage Completes Cutting-Edge Pilot-Scale Testing Platform to Accelerate Biomanufacturing Innovation
Bloomage, a global leader specializing in hyaluronic acid and other bioactive substance innovations, has announced the completion of its new pilot-scale te...
September 26, 2024 | News
Samsung Biologics Introduces Advanced Development Platforms to Boost Therapeutic Efficacy
Samsung Biologics showcases new innovative development platforms – S-AfuCHOTM and S-OptiChargeTM – at BioProcess International...
September 26, 2024 | News
Telix Pharmaceuticals to Acquire RLS Radiopharmacies, Expanding U.S. Manufacturing Footprint and Radiometal Production Network
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS Radiopharmacies), the only Joint Commission-accredited radiopharmacy n...
September 23, 2024 | News
RSSL Introduces £700K Laboratory for Advanced 3D Imaging & Metrology Services
RSSL, a leading food and life science contract research organisation, has announced the opening of a new laboratory providing a suite of advanced 3D ...
September 19, 2024 | News
Vetter’s Rankweil Site Expands as Project Orders Surge, Completing First 100 Aseptic Batches
An increase in project orders drives further site growth The first 100 aseptic batches at Vetter’s Rankweil site predict a successful future The ...
September 06, 2024 | News
Kaneka Japan Launches First New Plant in 54 Years to Boost Medical Device Production
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Are...
September 03, 2024 | News
The Critical Role of Chemistry, Manufacturing, and Control (CMC) in Pharmaceutical Product Development
The Development of new pharmaceutical products is a complex and multifaceted process that requires rigorous scientific, technical, and regulatory scrutiny....
August 09, 2024 | Opinion | By Vaibhav Patel, RAC-US, ASQ CQA Director of Quality Assurance and Regulatory Affairs, University of Minnesota
WuXi Biologics and Medigene Forge Strategic Partnership to Advance TCR-Guided T Cell Engagers for Cancer Treatment
Partnership leverages Medigene's leadership for T cell receptor (TCR) generation and characterization and WuXi Biologics' unique anti-CD3 mAb, its T cell...
August 09, 2024 | News
NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine
NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...
August 08, 2024 | News
Most Read
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
